PREVENT Risk Score and Use of Cardioprotective Agents in Type 2 Diabetes: An Analysis of NHANES 2013 to 2020

J Am Heart Assoc. 2024 Nov 5;13(21):e037456. doi: 10.1161/JAHA.124.037456. Epub 2024 Nov 4.

Authors

Lucas A Mavromatis¹, Dan Wang², Elizabeth Selvin², Jeffery S Berger³, Morgan E Grams^{1

2}, Jung-Im Shin²

Affiliations

¹ Division of Precision Medicine, Department of Medicine New York NY USA.
² Department of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore MD USA.
³ Leon H. Charney Division of Cardiology, Department of Medicine NYU Grossman School of Medicine New York NY USA.

PMID: 39494573
DOI: 10.1161/JAHA.124.037456

No abstract available

Keywords: GLP‐1RA; NHANES; PREVENT risk score; SGLT2i; diabetes.